Uses and production of chiral 3-hydroxy-γ-butyrolactones and structurally related chemicals

Enantiopure (S)-3-hydroxy-γ-butyrolactone (HGB) and its structurally related C3–C4 chemicals are an important target for chiral building blocks in synthetic organic chemistry. For the production of these compounds, more economical and practical synthetic routes are required. To date, chiral HGBs have been produced from petrochemicals and biomass, especially malic acids and carbohydrates. This report provides a short review on the production and application of enantiopure HGBs and their related compounds. Emphasis is focused mainly on synthetic routes using biocatalysis (microbial and chemoenzymatic) and application of these compounds. Biological methods have concentrated on devising different kinds of enzymes for the synthesis of the same compound as shown in the case of hydroxynitrile, a key intermediate of synthetic statins, and integrating unit processes for the optically active HGBs and 4-chloro-3-hydroxybutyrate with recombinant microorganisms expressing multiple enzymes. Chemical methods involve selective hydrogenation of carbohydrate-based starting materials. Both types of pathways will require further improvement to serve as a basis for a scalable route to HGBs and related compounds. Several of their synthetic applications are also introduced.

[1]  Tomoko Matsuda,et al.  Recent progress in biocatalysis for asymmetric oxidation and reduction , 2009 .

[2]  Anton Glieder,et al.  Yeast cell factories for fine chemical and API production , 2008, Microbial cell factories.

[3]  K. Sharpless,et al.  Asymmetric epoxidation of homoallylic alcohols. Synthesis of (-)-γ-amino-β(R)-hydroxybutyric acid (GABOB) , 1984 .

[4]  Jean-Rene Ella-Menye,et al.  Synthesis of chiral 2-oxazolidinones, 2-oxazolines, and their analogs , 2007 .

[5]  Toshio Suzuki,et al.  Industrialization of the Microbial Resolution of Chiral C3 and C4 Synthetic Units: From a Small Beginning to a Major Operation, a Personal Account , 2003 .

[6]  Qian-Qian Liu,et al.  Microbial production of R-3-hydroxybutyric acid by recombinant E. coli harboring genes of phbA, phbB, and tesB , 2007, Applied Microbiology and Biotechnology.

[7]  Andreas Liese,et al.  Biocatalytic ketone reduction—a powerful tool for the production of chiral alcohols—part II: whole-cell reductions , 2007, Applied Microbiology and Biotechnology.

[8]  H. Park,et al.  R-stereoselective amidase from Rhodococcus erythropolis No. 7 acting on 4-chloro-3-hydroxybutyramide. , 2008, Journal of microbiology and biotechnology.

[9]  Guijun Wang,et al.  Direct Conversion of (S)-3-Hydroxy-gamma-butyrolactone to Chiral Three-Carbon Building Blocks. , 1999, The Journal of organic chemistry.

[10]  Toshio Suzuki,et al.  Dual production of highly pure methyl (R)-4-chloro-3-hydroxybutyrate and (S)-3-hydroxy-γ-butyrolactone with Enterobacter sp. , 1999 .

[11]  Junhua Tao,et al.  Recent applications of biocatalysis in developing green chemistry for chemical synthesis at the industrial scale , 2008 .

[12]  Sang-Hyun Lee,et al.  A chemoenzymatic approach to the synthesis of enantiomerically pure (S)-3-hydroxy-γ-butyrolactone , 2008, Applied Microbiology and Biotechnology.

[13]  M. V. Filho,et al.  Chemoenzymatic synthesis of the chiral side-chain of statins: application of an alcohol dehydrogenase catalysed ketone reduction on a large scale , 2008, Bioprocess and biosystems engineering.

[14]  Guijun Wang,et al.  A simple three-step method for preparing homochiral 5-trityloxymethyl-2-oxazolidinones from optically active 3-hydroxy-γ-butyrolactones , 2000 .

[15]  K. Prather,et al.  Metabolic Engineering of Escherichia coli for Enhanced Production of (R)- and (S)-3-Hydroxybutyrate , 2009, Applied and Environmental Microbiology.

[16]  C. Sih,et al.  Stereochemical control of yeast reductions. 1. Asymmetric synthesis of L-carnitine , 1983 .

[17]  F. Conicella.  Development of chiral pharmaceutical fine chemicals through technology fusion , 2003 .

[18]  J. Hasegawa,et al.  Produciton of β-Hydroxycarboxylic Acids from Aliphatic Carboxylic Acids by Microorganisms : Studies on β-Hydroxycarboxylic Acids (II) , 1981 .

[19]  A. N. Deshmukh,et al.  A simple and practical approach to enantiomerically pure (S)-3-hydroxy-γ-butyrolactone: synthesis of (R)-4-cyano-3-hydroxybutyric acid ethyl ester , 2005 .

[20]  R. Hollingsworth.  Taming Carbohydrate Complexity: A Facile, High-Yield Route to Chiral 2,3-Dihydroxybutanoic Acids and 4-Hydroxytetrahydrofuran-2-ones with Very High Optical Purity from Pentose Sugars , 1999 .

[21]  M. Burk,et al.  Creation of a productive, highly enantioselective nitrilase through gene site saturation mutagenesis (GSSM). , 2003, Journal of the American Chemical Society.

[22]  Guijun Wang,et al.  Synthetic routes to l-carnitine and l-gamma-amino-beta-hydroxybutyric acid from (S)-3-hydroxybutyrolactone by functional group priority switching , 1999 .

[23]  M. Murcko,et al.  Crystal Structure of HIV-1 Protease in Complex with Vx-478, a Potent and Orally Bioavailable Inhibitor of the Enzyme , 1995 .

[24]  J. H. Edwards,et al.  Nitrilase-Catalysed Desymmetrisation of 3-Hydroxyglutaronitrile: Preparation of a Statin Side-Chain Intermediate , 2006 .

[25]  M. Kataoka,et al.  Novel bioreduction system for the production of chiral alcohols , 2003, Applied Microbiology and Biotechnology.

[26]  K. Prather,et al.  High-titer production of monomeric hydroxyvalerates from levulinic acid in Pseudomonas putida. , 2009, Journal of biotechnology.

[27]  James E. Leresche,et al.  Chemocatalysis and Biocatalysis (Biotransformation): Some Thoughts of a Chemist and of a Biotechnologist , 2006 .

[28]  A. Maureen Rouhi.  MIXED OUTLOOK FOR CUSTOM CHEMICALS , 2005 .

[29]  Sze Min Puah,et al.  Production of (R)-ethyl-3,4-epoxybutyrate by newly isolated Acinetobacter baumannii containing epoxide hydrolase , 2008, Applied Microbiology and Biotechnology.

[30]  Toshio Suzuki,et al.  Production of (S)-4-chloro-3-hydroxybutyrate by microbial resolution using hydrolase from Rhizobium sp. DS-S-51. , 2008, Journal of bioscience and bioengineering.

[31]  Atsuhiko Shinmyo,et al.  Improvement on production of (R)-4-chloro-3-hydroxybutyrate and (S)-3-hydroxy-gamma-butyrolactone with recombinant Escherichia coli cells. , 2006, Journal of bioscience and bioengineering.

[32]  Toshio Suzuki,et al.  Asymmetric hydrolysis of 2-hydroxy-carboxylic esters using recombinant Escherichia coli , 2007 .

[33]  Toshio Suzuki,et al.  Industrialization of the Microbial Resolution of Chiral C3 and C4 Synthetic Units: From a Small Beginning to a Major Operation, a Personal Account , 2003 .

[34]  Y. Choi,et al.  Biochemical characterization of Rhodococcus erythropolis N′4 nitrile hydratase acting on 4-chloro-3-hydroxybutyronitrile , 2008 .

[35]  F. Nomoto,et al.  There's No Industrial Biocatalyst Like Hydrolase: Development of Scalable Enantioselective Processes Using Hydrolytic Enzymes1 , 2003 .

[36]  Daniel Mink,et al.  Directed evolution of an industrial biocatalyst: 2-deoxy-D-ribose 5-phosphate aldolase. , 2006, Biotechnology journal.

[37]  Andreas Liese,et al.  Biocatalytic ketone reduction—a powerful tool for the production of chiral alcohols—part I: processes with isolated enzymes , 2007, Applied Microbiology and Biotechnology.

[38]  Michael Müller,et al.  Chemoenzymatic synthesis of building blocks for statin side chains. , 2005, Angewandte Chemie.

[39]  Paul N. Devine,et al.  Advances in the Enzymatic Reduction of Ketones , 2008 .

[40]  S. Schaus,et al.  Practical Access to Highly Enantioenriched C-3 Building Blocks via Hydrolytic Kinetic Resolution. , 1998, The Journal of organic chemistry.

[41]  John C Whitman,et al.  Improving catalytic function by ProSAR-driven enzyme evolution , 2007, Nature Biotechnology.

[42]  Hiroaki Yamamoto,et al.  Practical application of recombinant whole-cell biocatalysts for the manufacturing of pharmaceutical intermediates such as chiral alcohols , 2002 .

[43]  Johnathan E. Holladay,et al.  Top Value Added Chemicals From Biomass. Volume 1 - Results of Screening for Potential Candidates From Sugars and Synthesis Gas , 2004 .

[44]  R. Hollingsworth,et al.  Toward a carbohydrate-based chemistry: progress in the development of general-purpose chiral synthons from carbohydrates. , 2000, Chemical reviews.

[45]  S. Lee,et al.  Chiral compounds from bacterial polyesters: sugars to plastics to fine chemicals. , 1999, Biotechnology and bioengineering.

[46]  J. Tao,et al.  Challenges in the Development of an Efficient Enzymatic Process in the Pharmaceutical Industry , 2004 .

[47]  Oliver May,et al.  Biocatalytic Reductions: From Lab Curiosity to “First Choice” , 2008 .

[48]  S. Schaus,et al.  Highly Selective Hydrolytic Kinetic Resolution of Terminal Epoxides Catalyzed by Chiral (Salen)CoIII Complexes. Practical Synthesis of Enantioenriched Terminal Epoxides and 1,2-Diols. , 2002 .

[49]  M. Chartrain,et al.  Asymmetric bioreductions: application to the synthesis of pharmaceuticals , 2001 .

[50]  Xing Chen,et al.  A Novel One-Step Diastereo- and Enantioselective Formation of trans-Azetidinones and Its Application to the Total Synthesis of Cholesterol Absorption Inhibitors. , 1999, The Journal of organic chemistry.

[51]  Ann Thayer,et al.  COMPETITORS WANT TO GET A PIECE OF LIPITOR: Biocatalysis offers a variety of enantioselective routes to key chiral intermediates for the drug , 2006 .

[52]  A. Rouhi.  CUSTOM CHEMICALS: Custom producers of pharmaceutical active ingredients and advanced intermediates continue to adjust to challenging economic conditions , 2003 .

[53]  S. Hong,et al.  Biosynthesis of enantiopure (S)-3-hydroxybutyric acid in metabolically engineered Escherichia coli , 2008, Applied Microbiology and Biotechnology.

[54]  Alexander Varvak,et al.  Development of an efficient, scalable, aldolase-catalyzed process for enantioselective synthesis of statin intermediates. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Scott E Schaus,et al.  Highly selective hydrolytic kinetic resolution of terminal epoxides catalyzed by chiral (salen)Co(III) complexes. Practical synthesis of enantioenriched terminal epoxides and 1,2-diols. , 2002, Journal of the American Chemical Society.

[56]  Ramesh N. Patel.  Synthesis of chiral pharmaceutical intermediates by biocatalysis , 2008 .